On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Mayo Clinic Hospital

InstitutionResearch output, impact & collaborations

Mayo Clinic Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Mayo Clinic Hospital?

ScholarIQrecord summary

Mayo Clinic Hospital is a research organisation in Phoenix, US. OpenAlex records 14,050 works and 456,184 citations for it. 4,302 researchers list it as their most recent affiliation.

How many works does Mayo Clinic Hospital have?

ScholarIQindexed works

Mayo Clinic Hospital has 14,050 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Mayo Clinic Hospital have?

ScholarIQcitation count

Mayo Clinic Hospital has 456,184 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Mayo Clinic Hospital?

ScholarIQresearcher count

Mayo Clinic Hospital has 4,302 researchers in the ScholarIQ index.

What is the average h-index at Mayo Clinic Hospital?

ScholarIQavg h-index

Mayo Clinic Hospital has an average h-index of 55.8 in OpenAlex.

What is the ROR of Mayo Clinic Hospital?

ScholarIQror

The ROR for Mayo Clinic Hospital is on the source record.

What is the OpenAlex record for Mayo Clinic Hospital?

ScholarIQopenalex

The OpenAlex for Mayo Clinic Hospital is on the source record.

Who are the most-cited researchers behind Mayo Clinic Hospital?

ScholarIQtop researchers by citations
1
Steven E. Schild · Brain Metastases and Treatment
838 works39,998 citations
2
John T. Sharp · Rheumatoid Arthritis Research and Therapies
248 works39,075 citations
3
Javier Muñoz · Lymphoma Diagnosis and Treatment
284 works20,587 citations
4
A. J. Bell · Particle physics theoretical and experimental studies
125 works19,897 citations
5
Michael D. Crowell · Gastrointestinal motility and disorders
540 works17,801 citations

What are the most-cited papers on Mayo Clinic Hospital?

ScholarIQmost cited works
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Chen Hu, Kenneth Forster, Anthony M. Magliocco, Vivek S. Kavadi, Yolanda I. Garces, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Raymond B. Wynn, Christopher D. Koprowski, Joanne Meng, Jonathan J. Beitler, Rakesh Gaur, Walter J. Curran, Hak Choy
The Lancet Oncology. 20152,022 CitationsOPEN ACCESS
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green
Arthritis & Rheumatism. 20051,788 Citations
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20221,440 Citations
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20211,015 CitationsOPEN ACCESS
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes
Journal of the National Comprehensive Cancer Network. 20191,007 CitationsOPEN ACCESS

How much of the research on Mayo Clinic Hospital is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
33%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial